[go: up one dir, main page]

GB0207091D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB0207091D0
GB0207091D0 GBGB0207091.0A GB0207091A GB0207091D0 GB 0207091 D0 GB0207091 D0 GB 0207091D0 GB 0207091 A GB0207091 A GB 0207091A GB 0207091 D0 GB0207091 D0 GB 0207091D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0207091.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
ML Laboratories PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ML Laboratories PLC filed Critical ML Laboratories PLC
Priority to GBGB0207091.0A priority Critical patent/GB0207091D0/en
Publication of GB0207091D0 publication Critical patent/GB0207091D0/en
Priority to PCT/GB2003/001285 priority patent/WO2003080066A1/fr
Priority to AU2003226509A priority patent/AU2003226509A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0207091.0A 2002-03-26 2002-03-26 Method of treatment Ceased GB0207091D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0207091.0A GB0207091D0 (en) 2002-03-26 2002-03-26 Method of treatment
PCT/GB2003/001285 WO2003080066A1 (fr) 2002-03-26 2003-03-26 Utilisation de devazepide pour le traitement de la constipation
AU2003226509A AU2003226509A1 (en) 2002-03-26 2003-03-26 Use of devazepide for the treatment of constipation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207091.0A GB0207091D0 (en) 2002-03-26 2002-03-26 Method of treatment

Publications (1)

Publication Number Publication Date
GB0207091D0 true GB0207091D0 (en) 2002-05-08

Family

ID=9933725

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0207091.0A Ceased GB0207091D0 (en) 2002-03-26 2002-03-26 Method of treatment

Country Status (3)

Country Link
AU (1) AU2003226509A1 (fr)
GB (1) GB0207091D0 (fr)
WO (1) WO2003080066A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006094434A1 (fr) * 2005-03-10 2006-09-14 Maoji Zheng Type non invasif de dispositif d'aide a la defecation a l'aide d'une aspiration provoquee par une purge d'air et une reduction de pression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
WO2003080066A1 (fr) 2003-10-02
AU2003226509A1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
GB2393202B (en) Methods of well treatment
AU2003226301A8 (en) Method of treating cancer
AU2003278361A1 (en) Method of water treatment
AU2003256847A8 (en) Method of treating cancer
IL164266A0 (en) Treatment of gastroparesis
EP1577280A4 (fr) Procede de deuteration
ZA200409331B (en) Method of treating diabetes
GB0302572D0 (en) Method of treatment
GB0306309D0 (en) Method of treatment
GB0124124D0 (en) Methods of treatment
EP1493716A4 (fr) Procede de traitement des eaux usees
GB0112216D0 (en) Method of treatment
PL376350A1 (en) Sludge treatment method
GB0208897D0 (en) New method of treatment
GB0118892D0 (en) Method of treatment
AU2003252188A8 (en) Method of ore treatment
GB0217493D0 (en) Novel methods of treatment
AU2002951913A0 (en) Method of treatment
GB0221712D0 (en) Methods of treatment
GB0213198D0 (en) Method of treatment
GB0307544D0 (en) Treatment method
GB0327975D0 (en) Methods of treatment
GB0207091D0 (en) Method of treatment
GB0226275D0 (en) Method of treatment
GB0215583D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)